Nalbuphine and Flurbiprofen Axetil
PreclinicalSmall molecule
Nalbuphine and Flurbiprofen Axetil is one of 30 small molecule programs targeting Surgery. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
29
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
36 competitors in Surgery
#DrugCompanyPhaseTrials
1Alfenta
Jazz PharmaceuticalsApproved
Journavx
Vertex PharmaceuticalsApproved
Neo-Synephrine
EExela Pharma Sciences, LLC.
Approved
Nubain
AAultman Health Foundation
Approved
Desferal
Jazz PharmaceuticalsPhase 3
Marinol
Jazz PharmaceuticalsPhase 3
Levophed
GGeneral Hospital of Ningxia Medical University
Phase 3
Cardene
Sun Pharmaceutical Industries, Inc.Phase 2
Tukysa
PfizerPhase 2
Senna
MMedtronic - MITG
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SSun Yat-sen University